46100dkk
2,3 %
Date:2025-06-04Time:17:20:00Latest report:Q4-2024List:Mid CapTicker:GUBRA
Market Cap:7 537 mdkkEnterprise Value:7 499 mdkkNet Sales:265,7 mdkkEarnings:-36,5 mdkkEmployees:0ISIN:DK0062266474

Ratios

10-year key figure history for Gubra turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Gubra with index and moving average MA50 and MA200.

Stockprice:461,00
MA50:401,14
MA200:528,12
Price/MA200:-12,7 %
RSI (14):66,2
Price/MA50:14,9 %

Description

Gubra is a pharmaceutical company. The company's operations are focused on the early stages of drug development. They mainly conduct research and development in the field of metabolic and fibrotic diseases. The company's product portfolio includes several brands and pharmaceuticals, and operations are conducted on a global level, with the largest presence in North America and the Nordics. The head office is located in Hørsholm, Denmark.

Pharmaceuticals